Page last updated: 2024-08-24
fenofibric acid and Chronic Hepatitis C
fenofibric acid has been researched along with Chronic Hepatitis C in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Auwerx, J; Calmus, Y; Canva, V; Cheng, Y; Conti, F; Desreumaux, P; Dharancy, S; Dubuquoy, L; Gambiez, L; Malapel, M; Mathurin, P; Paris, JC; Perlemuter, G; Philippe, D; Podevin, P; Pol, S; Roskams, T; Schoonjans, K | 1 |
Other Studies
1 other study(ies) available for fenofibric acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
Topics: Biopsy; Carcinoma, Hepatocellular; Cell Line; DNA Primers; Fenofibrate; Gene Expression Regulation; Hepatitis C, Chronic; Humans; Immunohistochemistry; Liver; Liver Neoplasms; PPAR alpha; Transcription, Genetic; Transfection | 2005 |